A PharmD candidate reflects on the small, evidence-backed daily habits that helped her thrive—not just survive—through pharmacy school's most demanding years.
|Articles|October 11, 2010
- Volume 0 0
TEST TITLE
Author(s)TEST
Advertisement
TEST
Articles in this issue
over 18 years ago
Gout: A Big Pain in the Big Toeover 18 years ago
can you READ these Rxs?over 18 years ago
Case Studiesover 18 years ago
ASTHMA WATCHover 18 years ago
CHOLESTEROL WATCHover 18 years ago
ARTHRITIS WATCHover 18 years ago
DIABETES WATCHover 18 years ago
WOMEN'S HEALTH WATCHover 18 years ago
pharmacy TECHNOLOGY productsover 18 years ago
compounding HOTLINEAdvertisement
Related to this article
Understanding local health care priorities is essential to developing meaningful solutions.
Phase 2 DeLLphi-309 data show comparable activity in previously treated SCLC with less frequent dosing.
The most enduring resources a preceptor can give students are the confidence and tools to ask deeper questions.
Mounjaro becomes the first GIP/GLP-1 receptor agonist cleared to lower MACE risk, based on the SURPASS-CVOT head-to-head trial.
Two recent graduates share strategies for standing out in the competitive fellowship application process.
Community pharmacies are access points, safe places, and sources of stability when everything else feels uncertain.
Impostor syndrome prevalence in oncology pharmacists is a complex topic that is not well described.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Operationalizing Therapy and Managing Hypophosphatemia Risk at UPMC
2
Kidney Week 2026: What to Know for Nephrology's Biggest Meeting
3
FDA Approves Awiqli, Once-Weekly Insulin, for Children Aged 10 Years and Older With T2D
4
Flu Vaccination Linked to Fewer Severe Outcomes in Older Adults, Fewer ED Visits in Children
5